查找临床试验

已按「IgA 肾病」检索,对应国际通用词 IgA nephropathy

试验不在中国怎么办?

共找到 66 项正在招募的试验

数据更新于 00:18,每 5 分钟自动同步
正在招募II 期中国有中心NCT07614477

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

China

年龄 18 Years – 75 Years

Everest Medicines (China) Co.,Ltd.

正在招募不适用NCT01802034

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

United States

年龄 18 Years – 不限

The Rogosin Institute

正在招募II 期NCT06983028

Atacicept in Multiple Glomerular Diseases

United States

年龄 2 Years – 不限

Vera Therapeutics, Inc.

正在招募不适用NCT05234463

Study of the Link Between Complement Activation and IgA Nephropathy Severity

France

年龄 18 Years – 不限

University Hospital, Strasbourg, France

正在招募不适用NCT03929887

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

South Korea

年龄 不限 – 不限

Seoul National University Hospital

正在招募早期 I 期中国有中心NCT07498673

A Study of YKST02 in Participants With Primary IgA Nephropathy

China

年龄 18 Years – 75 Years

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

正在招募III 期中国有中心NCT04557462

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

United States、Argentina、Australia、Belgium、Brazil 等 12 国

年龄 18 Years – 100 Years

Novartis Pharmaceuticals

正在招募I 期NCT07248865

A Phase 1 Study of CLYM116 in Normal Healthy Volunteers

Australia

年龄 18 Years – 60 Years

Climb Bio, Inc.

正在招募IV 期NCT06676384

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

India

年龄 18 Years – 65 Years

Christian Medical College, Vellore, India

正在招募不适用NCT06926244

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

France

年龄 18 Years – 不限

Assistance Publique - Hôpitaux de Paris

正在招募不适用中国有中心NCT06760845

Raman Spectroscopy Diagnosis of Kidney Diseases

China

年龄 不限 – 不限

Zunsong Wang

正在招募II 期中国有中心NCT07354932

A Study of SHR-2173 in Participants With Primary IgA Nephropathy

China

年龄 18 Years – 不限

Guangdong Hengrui Pharmaceutical Co., Ltd